Olverembatinib for FGFR1-rearranged Neoplasms
Olverembatinib for FGFR1-rearranged Neoplasms
Recruiting · NCT05521204 · Registry updated 2022-08-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Olverembatinib for FGFR1-rearranged Neoplasms | Hemic and Lymphatic Diseases, Myeloproliferative Disorders, acute leukemia, bone marrow disorder, hematologic disorder, myeloproliferative neoplasm | Recruiting | Phase 2 | 2022-08-30 | NCT05521204 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| The First Affiliated Hospital of Soochow University | 164 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| First Affiliated Hospital of Soochow University | Suzhou | China | 5 |